Last 48 quarters of trend data · Healthcare · Diagnostics & Lab Testing
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 15.77 | 30.29 | 47.36 | 23.01 | 21.05 | 35.76 | — | 84.23 | 165.00 | 44.79 | 77.39 | — | — | — | — | — | — | — | — | — | — |
| — | -15.3% | — | -72.7% | -87.2% | -20.2% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 3.31 | 6.28 | 8.03 | 4.71 | 6.09 | 5.19 | 4.15 | 5.18 | 6.67 | 5.76 | 3.65 | 4.28 | 5.12 | 4.51 | 5.11 | 4.88 | 5.31 | 3.93 | 4.88 | 7.24 | 10.87 |
| — | +21.1% | +93.6% | -9.2% | -8.7% | -10.0% | +13.6% | +21.2% | +30.2% | +27.8% | -28.5% | -12.4% | -3.5% | +14.7% | +4.7% | -32.6% | -51.2% | -70.7% | -60.0% | -68.8% | -47.1% | |
| P/B Ratio | 1.49 | 2.66 | 3.48 | 1.95 | 2.62 | 2.18 | 1.77 | 1.99 | 2.69 | 2.27 | 1.48 | 1.48 | 1.93 | 1.54 | 1.70 | 1.49 | 1.59 | 1.13 | 1.34 | 1.81 | 2.67 |
| — | +22.2% | +96.6% | -1.9% | -2.8% | -4.2% | +19.8% | +34.1% | +39.7% | +47.3% | -13.4% | -0.5% | +21.5% | +35.9% | +27.6% | -17.7% | -40.6% | -61.2% | -51.8% | -48.2% | -60.4% | |
| P/FCF | 11.94 | 25.13 | 28.10 | 20.30 | 17.75 | 16.30 | 16.71 | 167.49 | 38.81 | 24.09 | 15.60 | — | 38.51 | 35.75 | 35.50 | — | 54.13 | 55.98 | — | — | 96.25 |
| — | +54.2% | +68.2% | -87.9% | -54.3% | -32.3% | +7.1% | — | +0.8% | -32.6% | -56.1% | — | -28.8% | -36.1% | — | — | -43.8% | — | — | — | -81.4% | |
| EV / EBITDA | 14.47 | 40.49 | 41.06 | 20.45 | 24.84 | 21.81 | 2252.24 | 67.69 | 71.34 | 33.76 | 35.21 | 391.20 | — | — | — | — | 344.39 | — | — | — | — |
| — | +85.7% | -98.2% | -69.8% | -65.2% | -35.4% | +6296.2% | -82.7% | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | 21.64 | 43.23 | 58.76 | 19.98 | 19.09 | 32.57 | 398.20 | 480.68 | 216.08 | 35.86 | 49.48 | — | — | — | — | — | — | — | — | — | — |
| — | +32.7% | -85.2% | -95.8% | -91.2% | -9.2% | +704.8% | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.6% | 70.6% | 72.2% | 72.3% | 74.4% | 69.2% | 69.0% | 69.5% | 66.4% | 68.2% | 68.1% | 64.5% | 70.1% | 69.4% | 61.8% | 68.2% | 66.6% | 65.6% | 65.6% | 65.0% | 66.0% |
| — | +2.0% | +4.7% | +4.1% | +12.1% | +1.5% | +1.3% | +7.7% | -5.3% | -1.7% | +10.2% | -5.4% | +5.3% | +5.7% | -5.9% | +4.9% | +0.9% | +2.3% | -3.9% | -1.8% | -2.4% | |
| Operating Margin | 14.3% | 10.9% | 15.3% | 17.1% | 18.4% | 17.4% | -4.0% | 2.5% | 3.5% | 10.4% | 4.0% | -4.8% | -36.2% | -35.2% | -8.9% | -12.7% | -6.7% | -12.8% | -14.7% | -22.5% | -18.3% |
| — | -37.3% | +477.8% | +575.9% | +424.1% | +67.8% | -200.5% | +152.8% | +109.7% | +129.4% | +145.2% | +62.3% | -435.7% | -175.1% | +39.5% | +43.4% | +63.1% | +53.7% | -8.6% | +81.8% | +21.6% | |
| Net Margin | 12.8% | 20.8% | 17.0% | 20.6% | 29.3% | 14.5% | -0.8% | 6.2% | 4.3% | 13.1% | 5.0% | -1.9% | -28.8% | -32.9% | -9.3% | -9.8% | -4.8% | -11.5% | -13.1% | -21.3% | -15.6% |
| — | +43.1% | +2352.2% | +235.3% | +578.9% | +10.9% | -115.0% | +419.8% | +115.0% | +139.8% | +153.9% | +80.4% | -501.9% | -184.8% | +28.9% | +54.0% | +69.4% | +50.7% | +20.2% | +81.3% | +32.9% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 5.3% | 2.2% | 1.9% | 2.2% | 3.2% | 1.5% | -0.1% | 0.6% | 0.4% | 1.3% | 0.5% | -0.2% | -2.7% | -2.8% | -0.8% | -0.8% | -0.4% | -0.8% | -0.9% | -1.3% | -1.0% |
| — | +44.6% | +2400.2% | +263.9% | +637.3% | +17.6% | -115.9% | +444.8% | +116.1% | +147.4% | +165.6% | +77.0% | -644.8% | -235.7% | +12.5% | +43.4% | +62.1% | +39.3% | +4.5% | +77.9% | +49.9% | |
| ROA | 4.9% | 2.1% | 1.7% | 2.0% | 3.0% | 1.4% | -0.1% | 0.5% | 0.4% | 1.2% | 0.5% | -0.2% | -2.5% | -2.6% | -0.7% | -0.7% | -0.3% | -0.8% | -0.8% | -1.2% | -0.9% |
| — | +45.9% | +2466.6% | +274.8% | +647.2% | +16.8% | -115.6% | +434.7% | +115.7% | +146.6% | +165.0% | +77.0% | -650.1% | -237.2% | +11.9% | +42.9% | +62.0% | +39.8% | +6.6% | +78.3% | +49.8% | |
| ROIC | 5.6% | 1.0% | 1.5% | 1.7% | 2.0% | 1.7% | -0.4% | 0.2% | 0.3% | 1.0% | 0.4% | -0.4% | -3.1% | -2.7% | -0.7% | -0.8% | -0.4% | -0.8% | -0.9% | -1.2% | -1.0% |
| — | -38.9% | +509.6% | +697.7% | +502.4% | +72.6% | -199.7% | +153.7% | +110.5% | +136.5% | +156.7% | +53.4% | -603.0% | -237.4% | +23.2% | +30.1% | +54.3% | +48.3% | -2.1% | +86.6% | +86.0% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 |
| — | -11.6% | -30.4% | -30.8% | -29.8% | +92.1% | +126.5% | +236.7% | +256.7% | +28.6% | +33.4% | -1.6% | -11.6% | -18.1% | -17.0% | -24.9% | -20.4% | -6.2% | -6.6% | -7.0% | -41.2% | |
| Debt / EBITDA | 0.41 | 1.81 | 1.44 | 1.34 | 1.27 | 1.43 | 229.17 | 6.11 | 4.87 | 1.10 | 2.00 | 15.03 | — | — | — | — | 12.96 | — | — | — | — |
| — | +26.0% | -99.4% | -78.0% | -73.9% | +30.3% | +11330.7% | -59.4% | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 8.15 | 5.56 | 9.16 | 9.31 | 8.15 | 6.23 | 5.43 | 5.10 | 4.73 | 5.08 | 4.44 | 5.00 | 4.66 | 4.74 | 4.46 | 4.49 | 3.97 | 4.09 | 3.96 | 3.81 | 3.79 |
| — | -10.8% | +68.9% | +82.5% | +72.1% | +22.7% | +22.2% | +1.9% | +1.5% | +7.2% | -0.5% | +11.4% | +17.5% | +15.9% | +12.7% | +17.8% | +4.8% | -10.8% | -61.5% | -65.6% | -83.1% | |
| Quick Ratio | 7.81 | 5.25 | 8.80 | 8.92 | 7.81 | 5.94 | 5.10 | 4.78 | 4.46 | 4.79 | 4.17 | 4.69 | 4.40 | 4.46 | 4.26 | 4.25 | 3.74 | 3.85 | 3.71 | 3.62 | 3.61 |
| — | -11.7% | +72.6% | +86.8% | +75.1% | +24.2% | +22.2% | +1.9% | +1.3% | +7.3% | -2.1% | +10.2% | +17.6% | +15.8% | +14.8% | +17.7% | +3.5% | -12.2% | -63.2% | -66.8% | -83.7% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | 16849.00 | 7362.00 | — | -15235.00 | -14885.00 | -2758.00 | -1154.86 | -687.20 | -144.49 | -136.81 | -236.11 | -175.83 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying VCYT stock.
Veracyte, Inc.'s current P/E is 15.8x. The average P/E over the last 4 quarters is 30.4x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Veracyte, Inc.'s current operating margin is 14.3%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Veracyte, Inc.'s business trajectory between earnings reports.